Literature DB >> 16345124

New confidence intervals for the difference between two sensitivities at a fixed level of specificity.

Gengsheng Qin1, Yu-Sheng Hsu, Xiao-Hua Zhou.   

Abstract

For two continuous-scale diagnostic tests, it is of interest to compare their sensitivities at a predetermined level of specificity. In this paper, we propose three new intervals for the difference between two sensitivities at a fixed level of specificity. These intervals are easy to compute. We also conduct simulation studies to compare the relative performance of the new intervals with the existing normal- approximation-based interval proposed by Wieand et al. Our simulation results show that the newly proposed intervals perform better than the existing normal-approximation-based interval in terms of coverage accuracy and interval length.

Mesh:

Year:  2006        PMID: 16345124     DOI: 10.1002/sim.2459

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  7 in total

1.  Comparison of two correlated ROC curves at a given specificity or sensitivity level.

Authors:  Leonidas E Bantis; Ziding Feng
Journal:  Stat Med       Date:  2016-06-20       Impact factor: 2.373

2.  A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range.

Authors:  William J Catalona; Alan W Partin; Martin G Sanda; John T Wei; George G Klee; Chris H Bangma; Kevin M Slawin; Leonard S Marks; Stacy Loeb; Dennis L Broyles; Sanghyuk S Shin; Amabelle B Cruz; Daniel W Chan; Lori J Sokoll; William L Roberts; Ron H N van Schaik; Isaac A Mizrahi
Journal:  J Urol       Date:  2011-03-17       Impact factor: 7.450

3.  The prostate health index selectively identifies clinically significant prostate cancer.

Authors:  Stacy Loeb; Martin G Sanda; Dennis L Broyles; Sanghyuk S Shin; Chris H Bangma; John T Wei; Alan W Partin; George G Klee; Kevin M Slawin; Leonard S Marks; Ron H N van Schaik; Daniel W Chan; Lori J Sokoll; Amabelle B Cruz; Isaac A Mizrahi; William J Catalona
Journal:  J Urol       Date:  2014-11-15       Impact factor: 7.450

4.  Confidence interval estimation of the difference between two sensitivities to the early disease stage.

Authors:  Tuochuan Dong; Le Kang; Alan Hutson; Chengjie Xiong; Lili Tian
Journal:  Biom J       Date:  2013-11-22       Impact factor: 2.207

5.  Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men.

Authors:  Claire de la Calle; Dattatraya Patil; John T Wei; Douglas S Scherr; Lori Sokoll; Daniel W Chan; Javed Siddiqui; Juan Miguel Mosquera; Mark A Rubin; Martin G Sanda
Journal:  J Urol       Date:  2015-01-28       Impact factor: 7.450

6.  A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer.

Authors:  Jin Song; Shiyong Ma; Lori J Sokoll; Rodrigo V Eguez; Naseruddin Höti; Hui Zhang; Phaedre Mohr; Renu Dua; Dattatraya Patil; Kristen Douglas May; Sierra Williams; Rebecca Arnold; Martin G Sanda; Daniel W Chan; Zhen Zhang
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.556

7.  Performance of lipid fingerprint-based MALDI-ToF for the diagnosis of mycobacterial infections.

Authors:  Ximena Gonzalo; Agnieszka Broda; Francis Drobniewski; Gerald Larrouy-Maumus
Journal:  Clin Microbiol Infect       Date:  2020-08-27       Impact factor: 8.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.